EP2648752
Mannaðlöguð mótefni gegn Liv-1 og notkun þeirra til að meðhöndla krabbamein
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.12.2011EP published:
15.2.2017EP application number:
11847198.6
EP translation filed:
28.2.2017Grant published:
15.3.2017EPO information:
European Patent Register
Max expiry date:
5.12.2031Expiry date:
5.12.2025Next due date:
31.12.2025
Title:
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
Timeline
Today
6.12.2011EP application
15.2.2017EP Publication
28.2.2017Translation submitted
15.3.2017Registration published
5.12.2025Expires
Owner
Name:
Seagen Inc.Address:
21823 30th Drive, S.E., 98021, Bothell, WA, US
Inventor
Name:
SMITH, Maria LeiaAddress:
BothellWashington, US
Name:
SUSSMAN, DjangoAddress:
BothellWashington, US
Name:
ARTHUR, WilliamAddress:
BothellWashington, US
Name:
NESTEROVA, AlbinaAddress:
BothellWashington, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
420291 PDate:
6.12.2010Country:
US
Number:
201161446990 PDate:
25.2.2011Country:
US
Classification
Categories:
C07K 16/28, C07K 16/30, A61K 39/395, C12P 21/08, A61K 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.11.2017
Expires: 5.12.2018
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.11.2018
Expires: 5.12.2019
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 19.11.2019
Expires: 5.12.2020
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.11.2020
Expires: 5.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.11.2021
Expires: 5.12.2022
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 21.11.2022
Expires: 5.12.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.11.2023
Expires: 5.12.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 11.11.2024
Expires: 5.12.2025
Payer: Árnason Faktor ehf.